Unknown

Dataset Information

0

Selective Anti-melanoma Effect of Phosphothioated Aptamer Encapsulated by Neutral Cytidinyl/Cationic Lipids.


ABSTRACT: BC15-31 is a DNA aptamer that targets heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1), which plays a crucial role in the process of pre-RNA maturation and is also essential for the rapid proliferation of tumor cells. In this research, we modified BC15-31 with a phosphorothioate (PS) backbone, LNA, and 2-O-MOE to enhance its stability and target affinity. In addition, a neutral cytidinyl lipid (DNCA) and a cationic lipid (CLD) were mixed to encapsulate modified aptamers with the aim of improving their cell permeability with low toxicity. Under the DNCA/CLD package, aptamers are mainly distributed in the nucleus. A modified sequence WW-24 showed an excellent selective anti-melanoma (A375 cells, ∼25 nM, 80%) activity, targeted to both hnRNP A1 and hnRNP A2/B1 found by the BLI experiment, and induced more early and late apoptosis in vitro, which also showed stronger antitumor effect and longer accumulation time in vivo. These results provide a new strategy for further clinical applications.

SUBMITTER: Wu J 

PROVIDER: S-EPMC8273494 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8957067 | biostudies-literature
| S-EPMC10220282 | biostudies-literature
| S-EPMC4051313 | biostudies-literature
| S-EPMC5736135 | biostudies-literature
| S-EPMC5998061 | biostudies-literature
| S-EPMC5453277 | biostudies-other
| S-EPMC4459899 | biostudies-literature
| S-EPMC5038357 | biostudies-literature
| S-EPMC6148748 | biostudies-literature
| S-EPMC4285367 | biostudies-literature